Neurodegenerative diseases such as Alzheimer's affect over 7 million people in Europe already – a number which is expected to grow rapidly with our ageing societies.
This video illustrates how the EU research project B-SMART aims to address the lack of causal therapies against neurodegenerative diseases through nanomedicine.
B-SMART has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 721058.
